Nuvation Bio Inc (NUVB)vsRevolution Medicines Inc (RVMD)
NUVB
Nuvation Bio Inc
$6.07
-3.34%
HEALTHCARE · Cap: $2.29B
RVMD
Revolution Medicines Inc
$203.77
+0.21%
HEALTHCARE · Cap: $44.44B
Smart Verdict
WallStSmart Research — data-driven comparison
Nuvation Bio Inc generates 22798% more annual revenue ($169.90M vs $742,000). RVMD leads profitability with a 0.0% profit margin vs -88.2%. NUVB earns a higher WallStSmart Score of 28/100 (F).
NUVB
Avoid28
out of 100
Grade: F
RVMD
Avoid24
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 556.0% year-over-year
Conservative balance sheet, low leverage
Areas to Watch
Trading at 8.3x book value
0.0% earnings growth
ROE of -45.7% — below average capital efficiency
Negative free cash flow — burning cash
Trading at 16.8x book value
0.0% earnings growth
0.0% margin — thin
Operating margin of 0.0%
Comparative Analysis Report
WallStSmart ResearchBull Case : NUVB
The strongest argument for NUVB centers on Revenue Growth. Revenue growth of 556.0% demonstrates continued momentum.
Bull Case : RVMD
The strongest argument for RVMD centers on Debt/Equity.
Bear Case : NUVB
The primary concerns for NUVB are Price/Book, EPS Growth, Return on Equity.
Bear Case : RVMD
The primary concerns for RVMD are Price/Book, EPS Growth, Profit Margin.
Key Dynamics to Monitor
NUVB profiles as a hypergrowth stock while RVMD is a value play — different risk/reward profiles.
NUVB carries more volatility with a beta of 1.53 — expect wider price swings.
NUVB is growing revenue faster at 556.0% — sustainability is the question.
NUVB generates stronger free cash flow (-5M), providing more financial flexibility.
Bottom Line
NUVB scores higher overall (28/100 vs 24/100) and 556.0% revenue growth. Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Nuvation Bio Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Nuvation Bio Inc., a clinical-stage biopharmaceutical company, is focused on developing therapeutic candidates for oncology. The company is headquartered in New York, New York.
Visit Website →Revolution Medicines Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Revolution Medicines, Inc., a precision clinical-stage oncology company, is focused on developing therapies to inhibit borderline targets in RAS-addicted cancers. The company is headquartered in Redwood City, California.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?